CVS Health Corporation (NYSE:CVS) declared a quarterly dividend on Thursday, September 22nd. Shareholders of record on Monday, October 24th will be given a dividend of 0.425 per share by the pharmacy operator on Thursday, November 3rd. This represents a $1.70 dividend on an annualized basis and a yield of 1.88%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Pinkerton Retirement Specialists LLC increased its position in CVS Health Corporation by 3,475.0% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,144 shares of the pharmacy operator’s stock valued at $110,000 after buying an additional 1,112 shares during the last quarter. Cantab Capital Partners LLP increased its position in CVS Health Corporation by 355.4% in the second quarter. Cantab Capital Partners LLP now owns 1,184 shares of the pharmacy operator’s stock valued at $113,000 after buying an additional 924 shares during the last quarter. MCF Advisors LLC increased its position in CVS Health Corporation by 20.0% in the second quarter. MCF Advisors LLC now owns 1,212 shares of the pharmacy operator’s stock valued at $116,000 after buying an additional 202 shares during the last quarter. Valley National Advisers Inc. increased its position in CVS Health Corporation by 0.5% in the second quarter. Valley National Advisers Inc. now owns 1,790 shares of the pharmacy operator’s stock valued at $171,000 after buying an additional 9 shares during the last quarter. Finally, FCG Advisors LLC acquired a new position in CVS Health Corporation during the second quarter valued at $200,000. Institutional investors and hedge funds own 80.96% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.13% on Thursday, reaching $90.38. 5,068,591 shares of the company traded hands. The firm has a market capitalization of $96.36 billion, a P/E ratio of 20.79 and a beta of 0.84. CVS Health Corporation has a 1-year low of $86.50 and a 1-year high of $106.67. The stock has a 50-day moving average price of $94.41 and a 200 day moving average price of $97.92.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.02. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The company had revenue of $43.70 billion for the quarter, compared to analysts’ expectations of $44.28 billion. During the same quarter last year, the company posted $1.19 earnings per share. The firm’s quarterly revenue was up 17.6% on a year-over-year basis. Analysts anticipate that CVS Health Corporation will post $5.86 EPS for the current fiscal year.

A number of research firms have issued reports on CVS. Deutsche Bank AG lifted their price target on CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a research note on Wednesday, June 22nd. Argus reissued a “buy” rating and set a $120.00 target price on shares of CVS Health Corporation in a research report on Thursday, August 4th. Leerink Swann reissued a “buy” rating on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Zacks Investment Research raised shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 3rd. Finally, Mizuho lifted their target price on shares of CVS Health Corporation from $108.00 to $111.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. Six investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. CVS Health Corporation currently has a consensus rating of “Buy” and an average target price of $113.02.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.